These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19949050)

  • 21. Ellipsometric studies of plasma protein adsorption on membrane polymers for blood purification.
    Mandenius CF; Ljunggren L
    Biomaterials; 1991 May; 12(4):369-73. PubMed ID: 1888805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of adsorption, filter material and point of dilution on antibiotic elimination by haemofiltration an in vitro study of levofloxacin.
    Choi G; Gomersall CD; Lipman J; Wong A; Joynt GM; Leung P; Ramsay SJ; Ho OM
    Int J Antimicrob Agents; 2004 Nov; 24(5):468-72. PubMed ID: 15519479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biocompatibility evaluation of polyamide hemofiltration.
    Panichi V; Bianchi AM; Andreini B; Casarosa L; Migliori M; De Pietro S; Taccola D; Giovannini L; Palla R
    Int J Artif Organs; 1998 Jul; 21(7):408-13. PubMed ID: 9745996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement depletion during haemofiltration with polyacrilonitrile membranes.
    Gasche Y; Pascual M; Suter PM; Favre H; Chevrolet JC; Schifferli JA
    Nephrol Dial Transplant; 1996 Jan; 11(1):117-9. PubMed ID: 8649617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lowering plasma levels of complement factor D with AN69 dialysis membranes.
    Strobel WM; Gürke T; Schifferli JA
    J Clin Apher; 1999; 14(4):188-9. PubMed ID: 10611630
    [No Abstract]   [Full Text] [Related]  

  • 26. Basic features of the polyamide membranes.
    Göhl H; Buck R; Strathmann H
    Contrib Nephrol; 1992; 96():1-25. PubMed ID: 1740044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elimination of linezolid by an in vitro extracorporeal circuit model.
    Schroeder TH; Hansen M; Stephan M; Hoffmann E; Unertl K; Krueger WA
    Int J Artif Organs; 2004 Jun; 27(6):473-9. PubMed ID: 15293354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetization influence on the performance of ferrosoferric oxide: polyacrylonitrile membranes in ultrafiltration of pig blood solution.
    Huang ZQ; Guo XP; Guo CL; Zhang Z
    Bioprocess Biosyst Eng; 2006 May; 28(6):415-21. PubMed ID: 16514522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sieving and extraction of peptides and proteins during hemofiltration: a systematic review
.
    Baird JS
    Clin Nephrol; 2017 Jun; 87(6):271-277. PubMed ID: 28211786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways.
    Salmon J; Cardigan R; Mackie I; Cohen SL; Machin S; Singer M
    Intensive Care Med; 1997 Jan; 23(1):38-43. PubMed ID: 9037638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous renal replacement therapies of acute renal failure and the polyamide membrane.
    Ronco C
    Contrib Nephrol; 1992; 96():111-23. PubMed ID: 1740046
    [No Abstract]   [Full Text] [Related]  

  • 32. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Joy MS; Matzke GR; Frye RF; Palevsky PM
    Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The polyamide membrane in hemodiafiltration.
    Gonella M; Calabrese G; Pratesi G; Mazzotta A; Vagelli G; Baldin C
    Contrib Nephrol; 1992; 96():99-105. PubMed ID: 1740054
    [No Abstract]   [Full Text] [Related]  

  • 34. Membrane biocompatibility: effects on cardiovascular stability in patients on hemofiltration.
    Davenport A; Davison AM; Will EJ
    Kidney Int Suppl; 1993 Jun; 41():S230-4. PubMed ID: 8320928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyacrylonitrile enzyme ultrafiltration and polyamide enzyme microfiltration membranes prepared by diffusion and convection.
    Dayal R; Godjevargova T
    Macromol Biosci; 2005 Mar; 5(3):222-8. PubMed ID: 15768441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro evaluation of high mobility group box 1 protein removal with various membranes for continuous hemofiltration.
    Yumoto M; Nishida O; Moriyama K; Shimomura Y; Nakamura T; Kuriyama N; Hara Y; Yamada S
    Ther Apher Dial; 2011 Aug; 15(4):385-93. PubMed ID: 21884474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro adsorption and sieving coefficient of ticarcillin-clavulanate during continuous haemofiltration.
    T P Wan W; Guerra Valero Y; Choi GYS; Ordóñez Mejia JL; Wallis SC; Joynt GM; Lipman J; Gomersall CD; Roberts JA
    Int J Antimicrob Agents; 2019 Aug; 54(2):261-264. PubMed ID: 30904466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pump assisted continuous venovenous hemofiltration for treating acute uremia.
    Canaud B; Garred LJ; Christol JP; Aubas S; Béraud JJ; Mion C
    Kidney Int Suppl; 1988 Mar; 24():S154-6. PubMed ID: 3163038
    [No Abstract]   [Full Text] [Related]  

  • 40. [Membranes for hemofiltration].
    Takesawa S
    Nihon Rinsho; 1991 Dec; 49 Suppl():401-5. PubMed ID: 1808290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.